Clare Arnott

About Associate Professor Clare Arnott

Global Director, Cardiovascular Program

  • Co-Director, Global Chronic & Complex Diseases
  • BMed Sci,
  • MBBS (Hons),
  • PhD,
  • FRACP,
  • FESC,
  • CF

A/Professor Clare Arnott is a Staff Specialist Cardiologist at Royal Prince Alfred Hospital with expertise in heart failure, CV imaging and women's heart disease and leads the Women's Heart Clinic. She is the Program Head of the Cardiovascular Division at the George Institute for Global Health where she leads several national and international cardiometabolic clinical trials. She sits on the CSANZ Scientific Board, the ANZACT Steering Committee and the Heart, Lung and Circulation Editorial Board. She is a Fellow of CSANZ and European Society of Cardiology.

Publications

View all publications

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial

Diabetes, Obesity and Metabolism Date published:

The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials

Journal of the American Geriatrics Society Date published:

Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease

Nephrology Dialysis Transplantation Date published:

Predicting Contrast-Associated Acute Kidney Injury

JAMA Network Open Date published:

Related Readings